Alayna Kenney is an associate in the London office of Latham & Watkins and a member of the firm’s Corporate Department.

Ms. Kenney advises clients on mergers and acquisitions, private equity, joint ventures, and general corporate matters.

Prior to qualification, Ms. Kenney trained in the firm’s London office, gaining experience in leveraged finance transactions, litigation, white collar defense and investigations, as well as corporate and restructuring transactions.

Ms. Kenney’s experience includes advising:

  • Eleusis, a life science company dedicated to unlocking the full therapeutic power of psychedelics, on multiple matters, including its:
    • Acquisition of Kalypso Wellness Centers, a leading provider of ketamine infusion therapies in the United States, and certain intellectual property
    • US$446 million merger with Silver Spike Acquisition Corp.
    • Sale to Beckley Psytech
  • Farfetch on the acquisition of YOOX Net-a-Porter Group from Richemont
  • Ligand Pharmaceuticals on its sale of Vernalis (R&D) Limited, a UK-based fragment and structure-based drug discovery research company, to HitGen
  • Nordic Capital on its US$846 million acquisition of Advanz Pharma
  • The Carlyle Group on its acquisition of a majority stake in luxury, streetwear, and sportswear retailer END
  • Threads on its divestment of a majority stake to Chalhoub

Bar Qualification

  • England and Wales (Solicitor)


  • LPC, BPP Law School, 2019
  • GDL, BPP Law School, 2018
  • BA in History, University of Durham, 2016
    First-Class Honours

Languages Spoken

  • English